One Word Cannabis

One Word Cannabis (also known as One World Cannabis) is an Israeli biopharmaceutical company and a subsidiary of OWC Pharmaceutical Research Corp. The company specializes in the research and development of cannabis-based medical products and proprietary delivery systems, including a sublingual tablet and a topical cream. Its pipeline targets several medical conditions such as multiple myeloma, psoriasis, fibromyalgia, and PTSD, with research conducted in collaboration with leading Israeli medical centers like Sheba Academic Medical Center. Although the company achieved early clinical milestones and established international partnerships, it has been inactive for several years and is currently classified as a delinquent filer on the OTC Expert Market.